Kangmei Pharma | 600518 - Current Assets



Kangmei Pharma reported CNY6.9B in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
Alaunos Therapeutics USD 2.76M 795K Dec/2024
Avita Medical AUD 57M 15.96M Dec/2024
Cspc Pharmaceutical CNY 21.89B 4.58B Dec/2024
Dianthus Therapeutics USD 263.6M 17.3M Jun/2025
Genomma Lab Internacional MXN 13.29B 235.58M Jun/2025
Hypermarcas BRL 5.61B 273.3M Jun/2025
Ionis Pharmaceuticals USD 2.58B 158.22M Jun/2025
IQVIA Holdings USD 6.35B 434M Jun/2025
Jiangsu Hengrui CNY 46.76B 10.79B Jun/2025
Kangmei Pharma CNY 6.9B 6.92M Jun/2025
Moderna USD 6.17B 595M Jun/2025
Organon & Co USD 4.62B 247M Jun/2025
Revvity USD 2.24B 81.76M Jun/2025
Sh Fosun Pharma CNY 34.34B 96.34M Jun/2025
Tectonic Therapeutic USD 290.85M 143.99M Jun/2025
Viatris USD 9.77B 152.2M Jun/2025
Wuxi Apptec CNY 42.59B 719.33M Jun/2025
Xeris Pharmaceuticals USD 185.58M 17.92M Jun/2025
Zz Pientze Pharmaceu 12.29B 113.34M Jun/2025